At a glance
ClinicalIndex Comparison RecordN/ACompleted· 152 enrolled
Drug / intervention
Hydrus Microstent +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Prospective, Multicenter, Randomized Comparison of the Hydrus to the iStent® for Lowering Intraocular Pressure in Primary Open Angle Glaucoma
In Brief
A clinical study evaluating Hydrus Microstent and iStent Trabecular Micro Bypass for Primary Open Angle Glaucoma and 2 related conditions. Completed, enrolled 152 participants across 1 site.
Detailed Summary
This clinical trial compares two implantable devices intended to lower the pressure inside the eye of glaucoma patients.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
Enrollment StartOct 2012
First PostedDec 2013
Primary CompletionAug 2017
Study CompletionJan 2018
TodayJul 2026
First PostedDec 30, 2013
Enrollment StartOct 1, 2012
Primary CompletionAug 1, 2017
Study CompletionJan 1, 2018
TodayJul 2, 2026
Enrollment to primary: 4.8 yearsPosted 12.5 years ago
Interventions
Hydrus Microstentdevice
Device inserted into Schlemm's canal to enhance aqueous flow from the anterior chamber.
iStent Trabecular Micro Bypassdevice
Device inserted into Schlemm's canal to enhance aqueous flow from the anterior chamber.